Grey matter (GM) involvement is clinically relevant in multiple sclerosis (MS). Using source-based morphometry (SBM), we characterized GM atrophy and its 1-year evolution across different MS phenotypes.

Association of Gray Matter Atrophy Patterns with Clinical Phenotype and Progression in Multiple Sclerosis / Rocca, M.A., Valsasina, P., Meani, A., Gobbi, C., Zecca, C., Rovira, A., Sastre-Garriga, J., Kearney, H., Ciccarelli, O., Matthews, L., Palace, J., Gallo, A., Bisecco, A., Lukas, C., Bellenberg, B., Barkhof, F., Vrenken, H., Preziosa, P., Filippi, M.. - In: NEUROLOGY. - ISSN 1526-632X. - 96:(2021), pp. e1561-e1573. [10.1212/WNL.0000000000011494]

Association of Gray Matter Atrophy Patterns with Clinical Phenotype and Progression in Multiple Sclerosis

Rocca, Maria A;Preziosa, Paolo;Filippi, Massimo
2021-01-01

Abstract

Grey matter (GM) involvement is clinically relevant in multiple sclerosis (MS). Using source-based morphometry (SBM), we characterized GM atrophy and its 1-year evolution across different MS phenotypes.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/110448
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 55
  • ???jsp.display-item.citation.isi??? 52
social impact